Can 3D ultrasonography evaluate fibrosis in Crohn's disease

3D ultrasonography for intestinal fibrosis in Crohn's disease - 3D ultrasonography for Crohn's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041143

Enrollment

Registered

2020-08-10

Start date

2020-08-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with CD who undergo CD-related surgery or MR enterography

Exclusion criteria

Exclusion criteria: 1. Lesions that did not undergo intestinal resection, such as strictureplasty 2. When the principal investigator considered not suitable.

Design outcomes

Primary

Measure	Time frame
Primary outcome is to evaluate the usefulness of 3D ultrasound parameters (wall thickening, blood flow, and elasticity) as a method to differentiate between inflammatory and fibrotic stenoses that occur in Crohn's disease.	—

Secondary

Measure	Time frame
Secondary outcome is to explore the immunological abnormalities that cause fibrosis by monitoring the immune abnormalities that cause stenosis by ultrasound.	—

Countries

Japan

Contacts

Public ContactShintaro Sagami

Kitasato University Kitasato Institute Hospital Center for Advanced IBD Research and Treatment

sagami@insti.kitasato-u.ac.jp03-3444-6161

Outcome results